Research output per year
Research output per year
Personal profile
Research interests
tumor angiogenesis, immunotherapy, vaccination
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Development of a cancer vaccine targeting tumor blood vessels, Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala Biomedical Center, Uppsala University, Uppsala, Sweden.
1 Mar 2008 → 11 May 2012
Award Date: 11 May 2012
Master, Faculty of pharmaceutical sciences, Utrecht University
1 Sept 1999 → 23 Nov 2005
Award Date: 23 Nov 2005
External positions
community pharmacist and store manager, Stadsapotheek Zaltbommel B.V., Zaltbommel
1 Jan 2006 → 1 Jul 2007
Keywords
- RM Therapeutics. Pharmacology
- immunotherapy
- vaccination
- cancer
- tumor angiogenesis
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Vaccination against Extracellular Vimentin for Treatment of Urothelial Cancer of the Bladder in Client-Owned Dogs
Engbersen, D. J. M., van Beijnum, J. R., Roos, A., van Beelen, M., de Haan, J. D., Grinwis, G. C. M., Schalken, J. A., Witjes, J. A., Griffioen, A. W. & Huijbers, E. J. M., 1 Aug 2023, In: Cancers. 15, 15, 3958.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Cancer Vaccination against Extracellular Vimentin Efficiently Adjuvanted with Montanide ISA 720/CpG
van Loon, K., Huijbers, E. J. M., de Haan, J. D. & Griffioen, A. W., 1 Jun 2022, In: Cancers. 14, 11, 2593.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus) -
Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)
Femel, J., van Hooren, L., Herre, M., Cedervall, J., Saupe, F., Huijbers, E. J. M., Verboogen, D. R. J., Reichel, M., Thijssen, V. L., Griffioen, A. W., Hellman, L., Dimberg, A. & Olsson, A-K., Oct 2022, In: Cancer Immunology, Immunotherapy. 71, 10, p. 2581 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access2 Citations (Scopus) -
Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors
Akbari, P., Katsarou, A., Daghighian, R., van Mil, L. W. H. G., Huijbers, E. J. M., Griffioen, A. W. & van Beijnum, J. R., 1 May 2022, In: Biochimica et Biophysica Acta - Reviews on Cancer. 1877, 3, 188701.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access8 Citations (Scopus) -
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy
van Beijnum, J. R., Huijbers, E. J. M., van Loon, K., Blanas, A., Akbari, P., Roos, A., Wong, T. J., Denisov, S. S., Hackeng, T. M., Jimenez, C. R., Nowak-Sliwinska, P. & Griffioen, A. W., 1 Dec 2022, In: Nature communications. 13, 1, 2842.Research output: Contribution to journal › Article › Academic › peer-review
Open Access12 Citations (Scopus)